MORN has fallen from approximately $360 to $198, cutting nearly 45% from its 2025 peak despite continued revenue growth, expanding margins and strong cash generation.

The monthly chart is now approaching one of its most attractive long-term technical configurations in years. The Master Buy Scanner V2 classifies Morningstar as a BUY / BUILD, although one important condition remains: the current monthly candle still needs to close.

Master Buy Scanner V2
Score: 3/3
Signal: BUY
Signal timeframe: 1M → 1M / 3W
Timeframe confidence: 1M OK
Action: BUY / BUILD
Decision: INVEST
BUY state: WAIT CLOSE
Entry quality: GOOD — 75%
Setup maturity: CONFIRM
Position size: FULL 100%
Top recent: YES
WT cross: YES
Band 1: GREEN
Combined band: GREEN 4/10
Bands synchronized: YES
Cycle: ACTIVE
Bars since BUY: Never
WT1 / WT2: -44.20 / -49.48

The setup is technically compelling. Both momentum curves have reached the scanner’s lower accumulation zone, the WT cross has occurred, the bands are synchronized and the broader cycle remains active.

However, the signal is not fully locked in yet. WAIT CLOSE means the monthly candle must finish in its current configuration before the BUY setup can be considered confirmed.

The combined band is also only 4/10, so this is not a maximum-momentum signal. It is better interpreted as a high-quality business entering a favorable long-term accumulation zone.

Business quality remains the core attraction

Morningstar’s latest results were considerably stronger than the stock-price performance suggests.

In Q2 2026:

Revenue increased 9.6% to $663.2 million.
Organic revenue increased 6.8%, or 8.2% excluding discontinued products.
Operating income increased 28.4%.
Adjusted operating income increased 22.7%.
Adjusted operating margin expanded from 23.7% to 26.5%.
Adjusted diluted EPS increased 29.2%.
Free cash flow increased 96.3% to $122.5 million.

These figures support the scanner’s maximum 3/3 business-quality score. Morningstar is not simply growing revenue—it is translating that growth into stronger margins, earnings and cash generation.

The company also repurchased $400 million of shares during the first half of 2026, reducing its share count by 5.6% since the end of 2025. That materially increases each remaining shareholder’s ownership of the business.

Growth is strong, but uneven

Morningstar’s portfolio contains several attractive data and analytics businesses, but the growth mix deserves attention:

Morningstar Credit: organic revenue +23.3%
Morningstar Retirement: revenue +17.0%
Morningstar Direct Platform: organic revenue +4.8%
PitchBook: organic revenue +4.9%
Morningstar Wealth: underlying organic revenue +5.3% excluding the retirement of Morningstar Office

Credit and Retirement are currently producing exceptional growth, while Direct and PitchBook—the company’s most important data platforms—are expanding more slowly. Direct license counts and PitchBook licensed users were relatively flat year over year.

This does not undermine the thesis, but it explains why the scanner’s future growth reading is less impressive than its historical growth score.

AI could be a catalyst rather than a threat

The market appears concerned that generative AI could weaken the competitive position of traditional financial-data platforms.

Morningstar is responding by embedding its proprietary data, research and intellectual property directly into AI workflows. Its integrations now include platforms such as Microsoft 365 Copilot and Perplexity, while the company aims to make all core datasets AI-ready by the end of 2026.

More than 20% of accounts with a Morningstar Direct license had already accessed its connector by mid-July, with similar early adoption at PitchBook. The company is also exploring consumption-based pricing designed to monetize AI-driven data usage.

The bullish interpretation is that AI increases the value and distribution of trusted, structured investment data rather than replacing it.

The bearish interpretation is that AI lowers switching costs, increases competition and requires continued spending before monetization becomes meaningful.

CRSP adds another long-term growth engine

Morningstar acquired the Center for Research in Security Prices to expand its index business, client footprint and proprietary equity database.

The acquired indexes have now been rebranded under Morningstar, including indexes used by major Vanguard funds. Morningstar has also signed a licensing agreement with CME Group for derivatives based on Morningstar Market Indexes and intends to expand CRSP’s data to a broader commercial audience.

This could strengthen Morningstar’s position across indexes, benchmarks, passive products and financial-data licensing.

Valuation

According to the scanner’s current inputs:

Value score: 6.5/7
Implied earnings multiple: approximately 18.75x
Implied cash-flow multiple: approximately 16.55x
Cash yield: approximately 6.6%
Current profit per share: approximately $10.55

Those are not distressed valuation levels, but they are attractive relative to Morningstar’s business quality, recurring revenue, margins and long-term record.

The scanner therefore sees this as a quality-at-a-reasonable-price setup, rather than a speculative deep-value recovery.

The main balance-sheet risk

Morningstar’s debt increased from approximately $1.1 billion at the end of 2025 to $1.7 billion in June 2026, reflecting the CRSP acquisition and significant share repurchases. Its reported leverage ratio reached approximately 1.9x.

The scanner also flags debt-to-equity at 1.86, its principal orange fundamental reading.

The debt remains manageable given Morningstar’s cash generation, but aggressive buybacks combined with acquisition spending reduce balance-sheet flexibility. Deleveraging and continued free-cash-flow growth will therefore be important confirmation points.

Key technical levels
Immediate support: $185–$190
Primary accumulation zone: $160–$175
Macro invalidation: monthly close below approximately $145
First resistance: $205–$220
Next confirmation zone: $240–$260
Major recovery resistance: $280–$300
Previous-cycle peak: approximately $350–$360

A confirmed monthly close around or above $200 would validate the scanner’s present configuration.

A subsequent move through $220 would provide stronger evidence that the rebound from the $150–$160 region is developing into a durable recovery rather than another temporary rally.

My classification: QUALITY BUY — WAIT FOR THE MONTHLY CLOSE

Morningstar combines several characteristics that are rarely present together:

Maximum business-quality score
Strong revenue and earnings growth
Expanding operating margins
Significant free-cash-flow growth
An increasingly attractive valuation
A deeply depressed monthly momentum reading
A developing long-term BUY signal

The principal caveats are the unconfirmed monthly close, increased leverage and slower growth within PitchBook and Morningstar Direct.

The scanner indicates FULL 100%, but because the BUY state remains WAIT CLOSE, I would interpret that as the potential final allocation after confirmation—not as a reason to deploy full exposure before the monthly candle is complete.

What would you do?

A) Start building a position around $198
B) Wait for the confirmed monthly close
C) Wait for a breakout above $220

Master Buy Scanner V2:

This is not financial advice. Technical signals can fail, and even high-quality businesses can continue declining when valuation, growth expectations or market sentiment deteriorate.